Greta Grimaud MBA is a seasoned professional with over two decades of experience in the pharmaceutical industry. Currently a Senior Oncology Account Specialist in Hematology at Pfizer, Greta previously championed Pfizer's DMD Gene Therapy initiative, which concluded in June 2024. Prior to this, Greta held various roles at companies such as GlaxoSmithKline, where they excelled as a Senior Sales Representative in Respiratory, and demonstrated leadership in研究参与 as a Research Assistant at the University of Utah. Greta's academic background includes an MBA from Colorado State University and a BS in Physiology and Chemistry from the University of Utah.
This person is not in the org chart
This person is not in any teams
This person is not in any offices